Celebrating 16 years of fundraising success, the Canadian Breast Cancer Foundation CIBC Run for the Cure raised $26.5 million. The largest, single-day, volunteer-led, national event to support breast cancer, this year’s Run attracted more than 170,000 Canadians in 53 communities across the country.
HHS Secretary Mike Leavitt announced that more than 90 percent of Medicare beneficiaries in a stand-alone Part D prescription drug plan (PDP) will have access to at least one plan in 2008 with premiums lower than they are paying this year. The open enrollment period for 2008 begins Nov. 15th and ends Dec. 31st.
A new Kaiser Permanente study, the first integrated survey of maternal depression, shows that more than one in seven women are depressed at some time during the nine months before becoming pregnant, during pregnancy, or in the nine months after childbirth.
One of the largest individual studies of the effects of alcohol on the risk of breast cancer shows that it makes no difference whether a woman drinks wine, beer or spirits (liquor). It is the alcohol itself (ethyl alcohol) and the quantity consumed that increases breast cancer risk. In fact, the increased breast cancer risk from drinking three or more alcoholic drinks a day is similar to the increased breast cancer risk from smoking a packet of cigarettes or more a day, according to Kaiser Permanente researchers Yan Li, MD, PhD and Arthur Klatsky, MD.
A hormone system linked to reducing food consumption appears to do so by increasing stress-related behaviors, according to a new study.
A network meta-analysis of 38 randomized controlled trials encompassing more than 18,000 patients found that the mortality risks associated with drug-eluting stents and bare-metal stents are similarly low. This analysis, the largest of its kind to date comparing drug-eluting stents (the CYPHER® Sirolimus-eluting Coronary Stent and the Taxus Stent) to bare-metal stents, appears this week in the medical journal The Lancet.
The U.S. Food and Drug Administration licensed 15 new blood typing tests that were previously unavailable in the United States.
GlaxoSmithKline (GSK) and Sepracor Inc. (Nasdaq: SEPR) announced an agreement for the commercialisation of Sepracor’s eszopiclone product for all markets worldwide (excluding the U.S., Canada, Mexico and Japan).
Some artificial food colourings may stimulate hyperactivity in children, revealed by a UK government agency in Britain.
Young women at risk of having a pulmonary embolism?a potential life-threatening blockage in a lung artery?should first undergo a ventilation/perfusion lung scan (V/Q scan) rather than a CT (computed tomography) angiogram, conclude authors in a paper published in the September Journal of Nuclear Medicine.